LifeSci Advisors, LLC

LifeSci Advisors is an organization that produces and publishes a research and periodic news updates. Our products are for informational purposes only. Investors should review all available information on any company mentioned, which may include, but not be limited to, the company’s annual report, quarterly report, press releases, as well as other regulatory filings. Our product is intended solely for informative purposes and is not solicitation or an offer to buy or sell any security. Additionally, it is not intended to be a complete description of the securities, markets, or developments referred to in the material. LifeSci Advisors cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. Additionally, LifeSci Advisors in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in our web site or accompanying research reports. Furthermore, LifeSci Advisors accepts no liability whatsoever for any direct or consequential loss arising from any use of our product, web site, or other contents. The reader bears responsibility for his/her own investment research and decisions and should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. LifeSci Advisors has received a fee from the subject companies presented on this site.

The information on this site is not intended to be, nor shall constitute, an offer to sell nor solicitation of any offer to buy any security. The information presented on this site is subject to change without notice, and LifeSci Advisors assumes no responsibility to update this information. Additionally, LifeSci Advisors and/or its officers and employees, and/or members of their families may have a long/short position in the securities mentioned and may make purchases and/or sales for their own account of those securities. LifeSci Advisors is not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (“SEC”) or with any state securities regulatory authority; our affiliate LifeSci Capital, LLC is registered as a broker-dealer with the SEC and a member of FINRA and SIPC. Any featured company logos or other third party logos are service/trademarks of their respective owners.


Carefully consider the respective investment objectives, risk factors and charges and expenses of BioSharesTM Biotechnology Products Fund and BioSharesTM Biotechnology Clinical Trials Fund (the "Funds") before investing. This and other information can be found in the Funds' prospectus. Read the prospectus carefully before investing.

Investing involves risk, including possible loss of principal.

The principal risks of investing in each Fund include biotechnology sector, market, index tracking, concentration, non-diversification and new adviser and sub-adviser risks, as well as fluctuations in net asset value. Funds that concentrate investments in a single sector will be more susceptible to factors affecting that sector and more volatile than funds that invest in many different sectors. The biotechnology sector in particular presents many investment risks including, but not limited to, heavy spending in research and development, government regulation, clinical trial risk, intellectual property risk, technological change and obsolescence, competition, product liability litigation and reimbursement risk. Funds that employ a passive investment strategy maintain investments in securities regardless of the current or projected performance of a specific security or sector which could cause the Funds’ returns to be lower than if the Funds employed an active strategy.

BioSharesTM Biotechnology Clinical Trials Fund may be subject to greater sector risk than a more broad-based biotechnology fund because it focuses on a narrower category of the biotechnology sector consisting of issuers with a primary product offering or product candidate that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. BioSharesTM Biotechnology Products Fund may be subject to greater sector risk than a more broad-based biotechnology fund because it focuses on a narrower category of the biotechnology sector consisting of issuers with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval.

Each Fund is an exchange-traded fund ("ETF"). The "net asset value" (NAV) of each Fund is determined at the close of each business day, and represents the dollar value of one share of the Fund; it is calculated by taking the total assets of the Fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV of each Fund is not necessarily the same as each such Fund’s intraday trading value. Fund investors should not expect to buy or sell shares at NAV because shares of ETFs such as the Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Funds. Thus, shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns.

Etfis Capital LLC serves as the investment adviser and LifeSci Index Partners, LLC serves as the sub-adviser to the Funds. The Funds are distributed by ETF Distributors LLC, an affiliate of Etfis Capital LLC. LifeSci Index Partners, LLC also serves as the index provider for the related indexes.

LifeSci Capital, LLC

Notice of Privacy Policy and Practice

LifeSci Capital, LLC (“LifeSci Capital”) recognizes and respects the privacy of our clients. For purposes of this notice, the terms “client” or “clients” includes both companies and individuals who provide nonpublic personal, confidential, and/ or proprietary information to LifeSci Capital. We provide this notice to you so that you will know what kinds of information we collect about our clients and the circumstances in which that information may be disclosed to third parties who are not affiliated with LifeSci Capital.

Collection of Client Information

We collect nonpublic personal, confidential, and/ or proprietary information about our clients from the following sources:

  • Engagement agreements, subscription agreements and other forms, which may include a client’s name, address, social security number or employer identification number, information about a client’s investment goals and risk tolerance, and other information;
  • Correspondence, written, telephonic, or electronic, between a client and LifeSci Capital or service providers to LifeSci Capital.

Disclosure of Client Information

We may disclose all of the client information outlined above to third parties who are not affiliated with LifeSci Capital:

  • As permitted by law;
  • To perform marketing services on our behalf or pursuant to a joint marketing agreement with another financial institution.
  • Security of Client Information

We require service providers to LifeSci Capital:

We may disclose all of the client information outlined above to third parties who are not affiliated with LifeSci Capital:

  • To maintain policies and procedures designed to assure only appropriate access to, and use of, information about clients of LifeSci Capital; and
  • To maintain physical, electronic, and procedural safeguards that comply with federal standards to guard nonpublic personal, confidential, and/ or proprietary information of clients of LifeSci Capital.

We will adhere to the policies and practices described in this notice regardless of whether you are a current or former client of LifeSci Capital.

Important Information You Need to Know about Opening a New Account

To help the government fight the funding of terrorism and money laundering activities, federal law requires financial institutions to obtain, verify and record information that identifies each person who opens an account.

What this means for you: When you open an account or become a client, we will ask for your business name, address (principle place of business or local office), a government issued identification number (such as a tax identification number), and other information that will allow us to identify your business. We will ask to see your business license and/or other identifying documents.

Information on SIPC

LifeSci Capital LLC is a member of the Securities Investors Protection Corporation (SIPC). SIPC has prepared an informative brochure which provides an understanding of SIPC, its role and how it protects you. The brochure can be obtained by visiting SIPC’s website or by calling SIPC at 202-371-8300.

Investor Education and Protection


LifeSci Capital LLC is a member of The Financial Industry Regulatory Authority (FINRA). FINRA makes available certain information on brokers, brokerage firms, investment adviser representatives and investment adviser firms through FINRA BrokerCheck®.

Through BrokerCheck, investors can:

  • Search for information about brokers and brokerage firms
  • Search for information about investment adviser firms and representatives
  • Obtain online background reports, if available
  • Link to additional resources such as educational tools for investors

You can request a BrokerCheck report by visiting, calling the BrokerCheck toll-free Hotline at (800) 289-9999, or submitting a request by U.S. mail to FINRA BrokerCheck, P.O. Box 9495 Gaithersburg, MD 20898-9495 or by fax to 240-386-4750.